BioXcel Therapeutics Inc. (BTAI)

3.81

1.65 (76.39%)

At close: Mar 03, 2025, 3:59 PM

3.43

-9.97%

After-hours: Mar 03, 2025, 07:59 PM EST

BioXcel Therapeutics Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15
Net Income	-179.05M	-165.76M	-106.93M	-82.17M	-32.97M	-19.27M	-4.54M	-2.12M	-636K
Depreciation & Amortization	318K	327K	297K	188K	156K	17K	1K	n/a	n/a
Stock-Based Compensation	18.61M	17.34M	19.45M	14.61M	3.14M	3.08M	1.61M	671K	n/a
Other Working Capital	5.07M	-123K	130K	-2.01M	-1.19M	-539K	-1K	-1K	174K
Other Non-Cash Items	3.1M	2.08M	46K	14.99M	3.45M	3.12M	1.61M	671K	182K
Deferred Income Tax	n/a	n/a	n/a	-14.99M	-3.45M	n/a	n/a	n/a	n/a
Change in Working Capital	2.02M	10.67M	4.98M	1.02M	2.39M	2.66M	736K	155K	174K
Operating Cash Flow	-155.01M	-135.34M	-82.15M	-66.35M	-27.28M	-13.51M	-2.2M	-1.29M	-280K
Capital Expenditures	-20K	-139K	-445K	-316K	-870K	-340K	n/a	-4K	-1K
Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	-870K	-340K	n/a	n/a	n/a
Investing Cash Flow	-20K	-139K	-445K	-316K	-870K	-340K	n/a	-4K	-1K
Debt Repayment	n/a	98.6M	n/a	n/a	n/a	-371K	438K	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	-9.02M	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-510K	-2.36M	1.45M	598K	201K	-615K	584K	1.3M	281K
Financial Cash Flow	26.52M	96.24M	102.45M	247.36M	18.01M	55.53M	3.08M	1.3M	281K
Net Cash Flow	-128.5M	-39.24M	19.85M	180.69M	-10.14M	41.68M	887K	n/a	n/a
Free Cash Flow	-155.03M	-135.48M	-82.6M	-66.67M	-28.15M	-13.85M	-2.2M	-1.3M	-281K